Viewing Study NCT00386750

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:57 PM
Ignite Modification Date: 2026-02-04 @ 11:36 AM
Study NCT ID: NCT00386750
Status: TERMINATED
Last Update Posted: 2012-04-27
First Post: 2006-10-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malaria View
None Falciparum View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Malaria View
None hearing View
None co-artemether View
None auditory View
None Plasmodium falciparum View
None marsh fever View
None Plasmodium infections View
None remittent fever View
None paludism View
None artemether View
None artemisinins View
None benflumetol View
None lumefantrine View